Stock Analiz

Intelligent Bio Solutions Inc. INBS

Medical/Dental Instruments · IPO 2020 · data as of November 13, 2026

$1.76Market cap $6M
Open the interactive analysis →

Intelligent Bio Solutions Inc. (INBS) is a healthcare company listed in the US with a market value of about $6M. In the twelve months to September 30, 2026 it had revenue of $4M and net income of -$12M, a net margin of -269.3%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 16% a year, a 5-year average ROIC of -155%.

About Intelligent Bio Solutions

Intelligent Bio Solutions is listed in the US and classified in medical/dental instruments, IPO year 2020. Revenue went from $188744 in 2020 to $4M in 2026, growth of about 67.8% a year. It was profitable in 0 of the last 7 years in our data. Its share count rose by 17492% over three years (dilution for shareholders).

Score: 1.6 / 5

Value0/5
Future growth4/5
Track record1/5
Financial health2/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.3
P/B0.8
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-206.5%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)38.1%
Revenue growth (5 yrs, per year)16.3%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-742.7%
ROIC (5-yr avg.)-155.0%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 7 years

Fiscal yearTTM2026202520242023202220212020
Revenue$4M$4M$3M$3M$1M$437146$2M$188744
Net income-$12M-$12M-$11M-$10M-$11M-$8M-$7M-$3M
Free cash flow—-$12M-$10M-$10M————
EPS (diluted)$-6.38$-8.44$-20.04$-63.80$-1270.00$-1359.59$-81.60$-44.40
Net margin-269.3%-294.9%-346.2%-326.4%-845.9%-1900.1%-355.3%-1676.2%
ROIC—-135.9%-257.4%-88.3%-193.8%-99.4%-29.2%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Intelligent Bio Solutions pay a dividend?

Not currently.

Is Intelligent Bio Solutions a good stock to buy?

We do not give buy or sell advice. Intelligent Bio Solutions scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.